356 related articles for article (PubMed ID: 10764250)
1. Glioma immunology and immunotherapy.
Parney IF; Hao C; Petruk KC
Neurosurgery; 2000 Apr; 46(4):778-91; discussion 791-2. PubMed ID: 10764250
[TBL] [Abstract][Full Text] [Related]
2. Cell-mediated immunotherapy: a new approach to the treatment of malignant glioma.
Yang L; Ng KY; Lillehei KO
Cancer Control; 2003; 10(2):138-47. PubMed ID: 12712008
[TBL] [Abstract][Full Text] [Related]
3. T cell immunity in patients with malignant glioma: recent progress in dendritic cell-based immunotherapeutic approaches.
Akasaki Y; Black KL; Yu JS
Front Biosci; 2005 Sep; 10():2908-21. PubMed ID: 15970545
[TBL] [Abstract][Full Text] [Related]
4. [Immunotherapy of gliomas].
Kito T; Yokota A
J UOEH; 2002 Sep; 24(3):301-11. PubMed ID: 12235960
[TBL] [Abstract][Full Text] [Related]
5. Immunotherapeutic approaches for glioma.
Okada H; Kohanbash G; Zhu X; Kastenhuber ER; Hoji A; Ueda R; Fujita M
Crit Rev Immunol; 2009; 29(1):1-42. PubMed ID: 19348609
[TBL] [Abstract][Full Text] [Related]
6. Exploitation of immune mechanisms in the treatment of central nervous system cancer.
Pollack IF; Okada H; Chambers WH
Semin Pediatr Neurol; 2000 Jun; 7(2):131-43. PubMed ID: 10914414
[TBL] [Abstract][Full Text] [Related]
7. Dendritic cell vaccines.
Yamanaka R; Kajiwara K
Adv Exp Med Biol; 2012; 746():187-200. PubMed ID: 22639169
[TBL] [Abstract][Full Text] [Related]
8. Immunotherapy for malignant glioma: current approaches and future directions.
Sikorski CW; Lesniak MS
Neurol Res; 2005 Oct; 27(7):703-16. PubMed ID: 16197807
[TBL] [Abstract][Full Text] [Related]
9. Novel immunotherapeutic approaches to glioma.
Yamanaka R
Curr Opin Mol Ther; 2006 Feb; 8(1):46-51. PubMed ID: 16506525
[TBL] [Abstract][Full Text] [Related]
10. Basic concepts in glioma immunology.
Parney IF
Adv Exp Med Biol; 2012; 746():42-52. PubMed ID: 22639158
[TBL] [Abstract][Full Text] [Related]
11. Dendritic cell immunotherapy for malignant gliomas.
Luptrawan A; Liu G; Yu JS
Rev Recent Clin Trials; 2008 Jan; 3(1):10-21. PubMed ID: 18474011
[TBL] [Abstract][Full Text] [Related]
12. Peptide-based immunotherapeutic approaches to glioma: a review.
Yamanaka R; Itoh K
Expert Opin Biol Ther; 2007 May; 7(5):645-9. PubMed ID: 17477802
[TBL] [Abstract][Full Text] [Related]
13. [Peptide vaccination therapy for malignant glioma].
Yamanaka R; Itoh K
Brain Nerve; 2007 Mar; 59(3):251-61. PubMed ID: 17370651
[TBL] [Abstract][Full Text] [Related]
14. Dendritic cell-based glioma immunotherapy (review).
Yamanaka R; Yajima N; Abe T; Tsuchiya N; Homma J; Narita M; Takahashi M; Tanaka R
Int J Oncol; 2003 Jul; 23(1):5-15. PubMed ID: 12792771
[TBL] [Abstract][Full Text] [Related]
15. Dendritic-cell- and peptide-based vaccination strategies for glioma.
Yamanaka R
Neurosurg Rev; 2009 Jul; 32(3):265-73; discussion 273. PubMed ID: 19214609
[TBL] [Abstract][Full Text] [Related]
16. Immunological challenges for peptide-based immunotherapy in glioblastoma.
Mohme M; Neidert MC; Regli L; Weller M; Martin R
Cancer Treat Rev; 2014 Mar; 40(2):248-58. PubMed ID: 24064197
[TBL] [Abstract][Full Text] [Related]
17. Immunotherapeutic strategies for malignant glioma.
Fenstermaker RA; Ciesielski MJ
Cancer Control; 2004; 11(3):181-91. PubMed ID: 15153842
[TBL] [Abstract][Full Text] [Related]
18. Dendritic cell-based immunotherapy for malignant gliomas.
Akasaki Y; Black KL; Yu JS
Expert Rev Neurother; 2005 Jul; 5(4):497-508. PubMed ID: 16026233
[TBL] [Abstract][Full Text] [Related]
19. Immunotherapy for malignant gliomas: emphasis on strategies of active specific immunotherapy using autologous dendritic cells.
De Vleeschouwer S; Van Gool SW; Van Calenbergh F
Childs Nerv Syst; 2005 Jan; 21(1):7-18. PubMed ID: 15452731
[TBL] [Abstract][Full Text] [Related]
20. Animal models for vaccine therapy.
Chung DS; Kim CH; Hong YK
Adv Exp Med Biol; 2012; 746():143-50. PubMed ID: 22639165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
